- Ares Management’s assets under management (AUM) reached $394.9 billion, showing a 16% increase year on year.
- The AUM surpassed the estimated figure which was $393.71 billion.
- The fee-related earnings were recorded at $274.2 million, a rise of 18% from the previous year.
- However, these earnings fell short of the estimated $287.2 million.
- The fee-paying AUM amounted to $247.7 billion, marking a 13% increase year on year.
- This figure was lower than the estimated $252.39 billion.
- The 3Q EPS (Earnings per Share) of Ares Management stood at $0.30.
- The company received 9 buy ratings, 7 hold ratings, and no sell ratings.
A look at Ares Management Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 3 | |
| Growth | 5 | |
| Resilience | 2 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Ares Management Corporation has received a score of 5 out of 5 for its Growth and Momentum, indicating a strong long-term outlook. The company has also earned a score of 3 out of 5 for its Dividend, showing that it has a reliable dividend policy in place. However, its Value and Resilience scores of 2 out of 5 suggest that investors should approach the company with caution.
As an asset management firm, Ares Management focuses on tradable credit, direct lending, private equity and real estate markets. It has a wide range of clients, including university endowments, pension and sovereign wealth funds, banks and insurance companies.
Overall, Ares Management Corporation appears to have a strong long-term outlook, although investors should be aware of the potential risks associated with its Value and Resilience scores.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
